<DOC>
	<DOCNO>NCT02243098</DOCNO>
	<brief_summary>The trial conduct Europe . The aim trial investigate influence semaglutide pharmacokinetics ( exposure trial drug body ) single dos atorvastatin digoxin healthy subject .</brief_summary>
	<brief_title>Investigating Influence Semaglutide Pharmacokinetics Single Doses Atorvastatin Digoxin Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Digoxin</mesh_term>
	<criteria>Male female , age 18 55 year ( inclusive ) time sign informed consent Body mass index 20.0 29.9 kg/m^2 ( inclusive ) Female pregnant , breastfeed intend become pregnant childbearing potential use adequate contraceptive method . Women childbearing potential must use effective method birth control throughout trial include 5 week followup period . Only highly effective method birth control accept ( i.e . one result less 1 % per year failure rate use consistently correctly implant , injectables , combine oral contraceptive , intrauterine device ) , sexual abstinence vasectomise partner Any clinically significant disease history , opinion investigator , systemic organ disease include : cardiac , pulmonary , gastrointestinal , hepatic , neurologic , renal , genitourinary endocrine , dermatologic hematologic disease Use prescription nonprescription systemic topical medicinal product ( include routine nonroutine vitamin herbal supplement , exclude paracetamol contraceptive ) within 3 week ( within 5 halflives medicinal product , whichever long ) prior Visit 2 ( first dose administration ) History drug/chemical substance abuse within 1 year screening , positive result urine drug test History alcohol abuse within 1 year screening , positive result alcohol urine test , consumption 21 unit ( male ) /14 unit ( female ) alcohol weekly ( one unit alcohol equal 250 mL beer lager , one glass ( 120 mL ) wine , 20 mL spirit ) Smoking last 3 month prior screen positive nicotine test</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>